Zobrazeno 1 - 10
of 304
pro vyhledávání: ''
Autor:
Marloes A. G. Elferink, Manon C.W. Spaander, Esther Toes-Zoutendijk, Evelien Dekker, Iris D. Nagtegaal, Geraldine R. Vink, Monique E. van Leerdam, Iris Lansdorp-Vogelaar, Sabine Siesling
Publikováno v:
European Journal of Cancer, 161, 38-43
European Journal of Cancer, 161, pp. 38-43
European Journal of Cancer, 161, 38-43. ELSEVIER SCI LTD
European journal of cancer, 161, 38-43. Elsevier
European Journal of Cancer, 161, 38-43. Elsevier Limited
European Journal of Cancer, 161, 38-43. Elsevier Ltd.
European Journal of Cancer, 161, pp. 38-43
European Journal of Cancer, 161, 38-43. ELSEVIER SCI LTD
European journal of cancer, 161, 38-43. Elsevier
European Journal of Cancer, 161, 38-43. Elsevier Limited
European Journal of Cancer, 161, 38-43. Elsevier Ltd.
Many countries had to suspend their colorectal cancer (CRC) screening pro-gramme as a result of the COVID-19 pandemic. This eventually may lead to postponed diag-noses of premalignant lesions and CRC, resulting in increased incidence or more advanced
Autor:
Michael Weichenthal, Patrick Terheyden, Edgar Dippel, Georg Lodde, Rudolf A. Herbst, Inga Möller, Lisa Zimmer, Dirk Schadendorf, Julia Kretz, Peter Mohr, Ralf Gutzmer, Jochen Utikal, Eleftheria Chorti, Johanna Matull, Claudia Pföhler, Annette Paschen, Luisa Richter, Anne Zaremba, Philipp Jansen, Friedegund Meier, Selma Ugurel, Carl M. Thielmann, Antje Sucker, Eva Hadaschik, Jens Ulrich, Klaus G. Griewank, Alexander Kreuter, Rajmohan Murali, Elisabeth Livingstone
Publikováno v:
Eur J Cancer
Background NF1-mutated tumours represent a small subset (10–15%) of melanomas, not sufficiently analysed in large clinical cohorts. This study investigated the largest multicentre collection of NF1-mutated melanomas to date. Methods This study anal
Autor:
Wei Wu, Lin Jinyi, Yan Wang, Yiyi Yu, Hang Jin, Qian Li, Luoyan Ai, Mengling Liu, Shan Yu, Suyao Li, Qing Liu, Tianshu Liu
Publikováno v:
European Journal of Cancer. 157:10-20
Combination of immune checkpoint inhibitor (ICI) and anti-vascular endothelial growth factor (VEGF) therapy has increasingly become a promising strategy in various tumors. However, the combination might be associated with increased cardiotoxicities.
Autor:
Minghua Ge, Yan-Yan Liu, Zhengdong Li, Liangfang Shen, Qingyuan Zhang, Yi Luo, Jifeng Feng, Ye Guo, W. Chen, Kun-Yu Yang, Xiaohui He, Kai Xue, Yan Sun, T. Lin, Xiao-Dong Zhu, Xiao Ming Huang, XinYing Chang, Chunmei Bai, Yan Zeng, Lin Wang
Publikováno v:
European Journal of Cancer. 156:35-45
Background The EXTREME regimen (chemotherapy [CT; cisplatin/carboplatin and 5-fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/
Autor:
Stéphane Champiat, Christophe Massard, Anne-Laure Voisin, Capucine Baldini, Benjamin Besse, Cedric Pobel, Vincent Thomas de Montpréville, Laurence Albiges, Christina Mateus, Jérôme Le Pavec, Samy Ammari, Aurélien Marabelle, Noémie Chanson, Patricia Pautier, Jean-Marie Michot, Patricia Romano-Martin, Charlotte Cabanié, François-Xavier Danlos, Caroline Even, Olivier Lambotte, Sophie Hans, Emilie Routier, A. Laparra, Celine Boutros, Corinne Balleyguier, Romain David Seban, Samuel Dolidon, Caroline Robert
Publikováno v:
European Journal of Cancer. 156:46-59
Sarcoid-like granulomatosis (SLG) reaction caused by immunotherapy remains poorly understood. This study aims to investigate the outcome of patients with cancer and SLG associated with immunotherapy.Between April 2016 and June 2020, 434 patients with
Autor:
Dorothy M. Gujral, Kevin J. Harrington, Win Soe, Aisha Miah, M. Emson, David Bernstein, Katie Wood, James P Morden, Amen Sibtain, Matthew Beasley, Deborah Gardiner, Nachi Palaniappan, Audrey Cook, Teresa Guerrero Urbano, Shelia Fisher, Tom Roques, M. Rizwanullah, Mehmet Sen, Paul Sanghera, Emma Hall, Christopher D Scrase, Vivian P Cosgrove, Christopher M. Nutting, Clare Griffin, Shanmugasundaram Ramkumar, Elizabeth Junor, Shreerang Bhide, Catherine M West, Bernadette Foran, Hisham Mehanna
Publikováno v:
European Journal of Cancer. 153:242-256
Background Radical (chemo)radiotherapy offers potentially curative treatment for patients with locally advanced laryngeal or hypopharyngeal cancer. We aimed to show that dose-escalated intensity-modulated radiotherapy (DE-IMRT) improved locoregional
Autor:
Ian King, Joseph Alexander Ward, Beth Russell, Maria J. Monroy-Iglesias, Mieke Van Hemelrijck, Aadil A. Khan, Kelvin Ramsey
Publikováno v:
European Journal of Cancer. 151:233-244
Background Lymphoedema after cancer treatment is a chronic and disabling complication that presents a significant health care burden during survivorship with limited treatment options. Vascularised lymph node transfer (VLNT) can reconstruct lymphatic
Autor:
Fien H. R. De Winter, Pieter Moons, Ella Roelant, Annelies Janssens, Lieselot Croes, Peter van Dam, Evelien Smits, Hans Prenen, Marc Peeters, An Hotterbeekx, Zwi N. Berneman, Manon T. Huizing, Zainab Amajoud, Wim Vanden Berghe, Leander Meuris, Christof Vulsteke, Samir Kumar-Singh
Publikováno v:
European Journal of Cancer
Background: Coronavirus disease (COVID-19) is interfering heavily with the screening, diagnosis and treatment of cancer patients. Better knowledge of the seroprevalence and immune response after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-C
Autor:
Gabi Tarcic, Razelle Kurzrock, Ori Zelichov, Shumei Kato, Suzanna Lee, Michael Vidne, Ryosuke Okamura, Robert Porter
Publikováno v:
European Journal of Cancer. 149:184-192
Background RAS variant–related functional impact on the mitogen-activated protein kinase (MAPK) pathway, and correlation between MAPK activation and MAPK/ERK kinase (MEK) inhibitor responsiveness, is not established. Patients and methods Of 1,693 t
Autor:
Cecilia Becattini, Giancarlo Agnelli, Melina Verso, Rupert Bauersachs, Menno V. Huisman, Andrés Muñoz, Mario Mandalà, Giorgio Vescovo
Publikováno v:
European Journal of Cancer, 148, 371-381. ELSEVIER SCI LTD
Background: Whether concomitant administration of anticancer agents influences the efficacy and safety of oral anticoagulants in patients treated for cancer-associated venous thromboembolism (VTE) is undefined. The pharmacological interaction between